Sovereign immunity: a venue-dependent protection

A recent University of Texas dispute perfectly illustrates the differing role sovereign immunity takes in proceedings at the Patent Trial and Appeal Board and district court, say Simon Roberts, Nitya Anand and Eric Wang of Hogan Lovells.

• The curious case of Wuhan’s Institute of Virology and remdesivir
• EPO’s new examination guidelines: what you need to know
• The uncertain future of antibody claims

More features